STOCK TITAN

Cano Health Inc - CANO STOCK NEWS

Welcome to our dedicated news page for Cano Health (Ticker: CANO), a resource for investors and traders seeking the latest updates and insights on Cano Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cano Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cano Health's position in the market.

Rhea-AI Summary
Cano Health sells assets for $66.7 million, improving balance sheet and focusing on Florida market. Expects to remain in compliance with debt covenants and has $109 million liquidity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
none
-
Rhea-AI Summary
Cano Health notified by NYSE of non-compliance with Listing Rule due to low stock price. Company plans to increase stock value through business strategy and considers reverse stock split. Largest stockholder supports reverse stock split. Company remains committed to driving strategy and evaluating strategic interest.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.11%
Tags
none
-
Rhea-AI Summary
Mark Kent appointed as CEO of Cano Health, replacing Dr. Marlow Hernandez
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.03%
Tags
management
Rhea-AI Summary
Cano Health plans to sell the company and exit operations in California, New Mexico, Illinois, and Puerto Rico. Q2 2023 financial results show an increase in total membership and revenue, but a net loss and lower adjusted EBITDA. MRA revenue was lower than expected, leading to higher medical costs. The company is also restructuring operations, reducing its workforce, and assessing divestiture of non-core assets. Liquidity is low, and there are concerns about the company's ability to continue as a going concern. 2023 guidance has been withdrawn. Shares issued and outstanding are approximately 539 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-73.03%
Tags
-
Rhea-AI Summary
Cano Health, Inc. has rescheduled its second quarter 2023 earnings release and conference call to tomorrow afternoon. The earnings release and call will review the business and financial results. To access the live call and webcast, please refer to the provided details.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.65%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.3%
Tags
conferences earnings
Rhea-AI Summary
Group Holding ~35% Stake Issues Letter to Cano’s Stockholders Regarding the Current Board’s Latest Failures and the Importance of Continuing to Provide Feedback to the Failed Directors
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.76%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.84%
Tags
none
-
Rhea-AI Summary
Cano Health, Inc. announces the resignation of CEO Dr. Marlow Hernandez and the appointment of Mark Kent as interim CEO. The largest single stockholder group calls for a board reconstitution overseen by independent directors. The board refuses to accept stockholders' mandate for change. The group urges the board to appoint independent candidates Guy P. Sansone and Joseph Berardo, Jr. as directors. The current board's actions are criticized for lacking appropriate corporate governance and oversight.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.6%
Tags
management
Rhea-AI Summary
Cano Health, a value-based primary care provider, announces a change in executive leadership. Mark Kent is appointed as Interim CEO while an external search is conducted for a permanent successor. Dr. Marlow Hernandez steps down as CEO but remains on the Board of Directors. The company also plans to refresh the Board with new independent directors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
Cano Health Inc

NYSE:CANO

CANO Rankings

CANO Stock Data

12.43M
1.25M
43.43%
34.34%
19.99%
General Medical and Surgical Hospitals
Health Care and Social Assistance
Link
US
Miami

About CANO

Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico.